Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
Gold edged higher on Tuesday morning, but the metal remained on course to notch its biggest monthly decline in almost 17 years.
Porepunkah has been in the spotlight since Dezi Freeman shot dead two police officers last year. Grouped from 4 articles across 3 sources.
US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers The US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if…
The winning bidder — along with up to seven guests — will join Buffett and the Currys for an exclusive lunch in Omaha, Nebraska.
Government told to focus on transition to mix of wind, solar, tidal and nuclear energy More drilling in the North Sea would do nothing to improve the UK’s energy security, former military leaders have said, as a new…